COVID-19 VACCINES: ADVERSE EVENTS FOLLOWING IMMUNISATION
Current Allergy and Clinical Immunology
; 35(1):16-22, 2022.
Article
in English
| EMBASE | ID: covidwho-2058971
ABSTRACT
Patients rely on healthcare providers as their most credible and frequent source of vaccine information. It is therefore crucial that healthcare providers are informed and have evidence-based, objective and clear guidance on vaccine efficacy and specific adverse events following immunisation (AEFI). Reported serious AEFIs are extremely rare for the COVID-19 vaccines. This article discusses the main AEFIs attributed to COVID-19 vaccines, including neurological complications of Guillain-Barré syndrome (GBS) and acute transverse myelitis (ATM), thrombosis;cardiac complications, including myocarditis, pericarditis and cardiomyopathy;and allergic reactions such as anaphylaxis, urticaria and skin rashes. The benefits of COVID-19 vaccination outweigh the risks;however, it is important that healthcare providers are aware of the risks and know how to recognise and manage them.
Full text:
Available
Collection:
Databases of international organizations
Database:
EMBASE
Topics:
Vaccines
Language:
English
Journal:
Current Allergy and Clinical Immunology
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS